As a 501(c)(3) nonprofit, we depend almost entirely on grassroots donations. Please consider making a donation.
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

Search 14,417 Media Articles

search

Our dangerous fear of pain
2019-11-27, Washington Post
https://www.washingtonpost.com/outlook/2019/11/27/our-dangerous-fear-pain/?ar...

One of the first things I learned about pain was its value. I was a third-year medical student in 1976. We were ... encouraged to listen carefully to the patients experience of pain, the timing, the duration and any factors that made it better or worse. Forty years later, our concept of pain couldnt be more different. Instead of learning from pain, we now regard it as an illness in and of itself. Insurance companies, health-care providers and drugmakers have all worked to increase the publics fear of pain, leading us to see it as something to be treated, eliminated, banished never lived with or accommodated or managed lest it destroy us. They turned our natural fear into big business; our fee-for-service system has multiplied treatments based primarily on the financial rewards for pharmaceutical companies, doctors and hospitals. That attitude shift is perhaps the most overlooked explanation for an opioid crisis that kills tens of thousands of Americans every year. A healthy fear of pain ... protects us from injury and reminds us to allow time for healing. But otherwise, the fear of pain, and the belief that a pain-free existence is optimal or even possible, has been a catastrophe for patients. Before the opioid revolution, doctors understood that pain was important to keeping us safe, to be lived with and managed. Even if this meant we bore frequent episodes of discomfort, that was better than the nationwide crisis America faces today. Life isnt pain free. If we want to end the epidemic of addiction, we need to relearn that lesson.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.


Purdue Pharma to pay $270 million to settle historic Oklahoma opioid lawsuit
2019-03-26, CNN News
https://www.cnn.com/2019/03/26/health/purdue-pharma-oklahoma-opioid-lawsuit-s...

Purdue Pharma has agreed to pay $270 million to settle a historic lawsuit brought by the Oklahoma attorney general, who accused the OxyContin maker of aggressively marketing the opioid painkiller and fueling a drug epidemic that left thousands dead in the state. The settlement comes after Purdue [sought] to delay the start of the trial, which is scheduled for May 28. Attorney General Mike Hunter said ... that $102.5 million of the settlement would be used to help establish a national addiction treatment and research center at Oklahoma State University. The company will also provide $20 million of addiction treatment and opioid rescue medications to the center. A remaining $12.5 million from the settlement will be used directly to help cities and counties with the opioid crisis. The Sackler family, who founded and own Purdue Pharma, will also contribute $75 million over the next five years to the treatment and research center. The lawsuit was brought by Hunter against some of the nation's leading makers of opioid pain medications, alleging that deceptive marketing over the past decade fueled the epidemic in the state. Hunter has said the defendants - Purdue Pharma, Johnson & Johnson, Teva Pharmaceuticals, Allergan and others - deceived the public into believing that opioids were safe for extended use. The settlement was only with Purdue Pharma, and the other defendants are still scheduled to go to trial. Thirty-six states have brought cases against Purdue and other opioid drugmakers.

Note: Many doctors also profited from excessive prescribing of dangerous opioids. And according to a former DEA agent, Congress helped drug companies fuel the opioid epidemic. For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.


WHO Foundation’s growing ‘dark money’ problem raises conflict of interest concerns
2025-07-31, US Right to Know
https://usrtk.org/bill-gates/who-foundations-growing-dark-money-problem-raise...

The transparency of donations to the World Health Organization (WHO) Foundation—an independent body that seeks funds from across industry, civil society and governments, and awards grants to the WHO — has plummeted over its first 3 years of operations, a new analysis has found. The analysis found that the majority of donors are not publicly disclosed, including some unnamed gifts as big as $11 million, which raises concerns about the potential “level of outside influence and role of commercial interests in setting WHO priorities,” the researchers wrote. In 2020, the foundation was set up to solicit funds from a wider range of donors than the WHO can directly accept, including wealthy individuals and corporations. Some academics and civil society organizations are concerned that accepting donations from industry, such as businesses selling alcohol and infant formula, poses a conflict of interest. Evidence suggests that some companies use donations “as opportunities to distract or reframe product harms.., and assist wider lobbying efforts against public health regulation,” wrote the authors of the new analysis. Using a scale to judge transparency in donations developed by Open Democracy, an independent international media platform, the researchers gave the WHO Foundation a D grade. This grade is for organizations that only name a minority of funders and not in a systematic way, putting it on par with some ‘dark money’ think tanks.

Note: Concerns about WHO’s growing dependence on opaque funding are not abstract. Past investigations show how Purdue Pharma influenced WHO opioid guidelines to expand sales globally and how Coca-Cola–linked consultants shaped WHO’s aspartame reviews. Bill Gates’ hundreds of millions to WHO now give him outsized influence to prioritize corporate interests under the guise of public health philanthropy, which have led to mass suicides in India, worsening environmental degradation and poverty in Africa, and increasing corporate control over the media.


Supreme Court opioid case makes it harder to shield wealth in bankruptcy
2024-06-29, Washington Post
https://www.washingtonpost.com/business/2024/06/29/bankruptcy-supreme-court-p...

A Supreme Court ruling against the opioid company Purdue Pharma ... substantially raised the bar for executives and owners trying to shield their wealth. Johnson & Johnson, Boy Scouts of America and Rite Aid are among the entities trying to handle a vast number of lawsuits in bankruptcy court, seeking to resolve all claims in a single settlement. These proceedings have echoes of the Purdue Pharma case decided by the Supreme Court on Thursday, in which the Sackler family, which owns the bankrupt opioid-maker, offered plaintiffs about $6 billion of the $11 billion they extracted from the company. In exchange, family members would have received immunity from future lawsuits, without filing for bankruptcy themselves. A 5-4 Supreme Court held that settlement was inadequate. Its ruling threw the massive bankruptcy case against Purdue Pharma into doubt after years of court battles over the company’s role in the nation’s opioid epidemic. The decision also adds a fresh wrinkle to a controversial legal strategy, called the Texas two-step, in which companies use a Texas law to split into separate companies and shift a large volume of legal claims onto the newly created entity. In the second step, the entity carrying the lawsuits files for bankruptcy and seeks to release its parent organization from all liability in exchange for a payout. Johnson & Johnson transferred some of its assets and all of the legal claims against it over asbestos-tainted talcum powder into a new legal entity that filed for Chapter 11. Boy Scouts of America ... agreed to pay $2.5 billion to settle claims of sexual abuse in bankruptcy court, a deal that shields from future litigation insurance companies as well as schools, churches and community organizations involved with the nonprofit.

Note: For more like this, read about how powerful corporations use the bankruptcy system to dodge lawsuits over sexual abuse and deadly products. Along US opioid industry lines, read how the industry operated like a drug cartel. Watch our Mindful News Brief video on how the deadly War on Drugs protects the activities of the rich and powerful: military-intelligence interests within the US government, big banks, Big Pharma, and drug cartels.


FDA Approved — And Ineffective
2025-06-05, The Lever
https://www.levernews.com/fda-approved-and-ineffective/

The woman, in her 60s, was losing her eyesight. [She] happened to be taking Elmiron, a drug for a bladder condition called interstitial cystitis. By the end of 2024, hundreds of patients on Elmiron had suffered vision loss or blindness. Others taking the drug were even more unlucky. Dozens of patient deaths associated with Elmiron were reported to the Food and Drug Administration (FDA), and 45 patients were hospitalized with severe colitis. Another problem? There’s no good evidence that Elmiron works. When the government approved Elmiron in 1996, the manufacturer provided close to zero data that the drug effectively treated interstitial cystitis. Elmiron is just one of hundreds of drugs that have been approved by the FDA over the last several decades on the basis of flimsy or nonexistent evidence. Drug companies have been allowed to market hundreds of prescription drugs to doctors and sell them to unsuspecting patients despite glaringly inadequate evidence that they offer any benefit and in many cases amid clear signs that they pose a risk of serious, often irreparable harm. From January 2013 until Dec. 31, 2022, the FDA approved 429 drugs, most of which were authorized on the basis of inadequate evidence that they worked, according to a database of government records created for this investigation. In the U.S. alone, an estimated 128,000 people are killed each year by side effects of prescription drugs that are properly prescribed. That number excludes opioid overdoses and is more than deaths from all illegal drugs combined.

Note: This article is also available here. A JAMA study reveals how Big Pharma spends more on ads for low-benefit drugs to push consumer demand for treatments doctors are less likely to prescribe. For more along these lines, read our concise summaries of news articles on government corruption and Big Pharma profiteering.


Revolving door redux: The DEA’s recently departed No. 2 returns to a Big Pharma consulting firm
2023-09-20, Associated Press
https://apnews.com/article/dea-opioids-fentanyl-cocaine-drugs-pharmaceutical-...

Louis Milione retired from the DEA a second time this summer amid reporting by The Associated Press on potential conflicts caused by his prior consulting for the pharmaceutical industry. Less than three months later, Milione again landed a plum job at Guidepost Solutions, a New York-based firm hired by some of the same companies he had been tasked with regulating when he returned to the DEA in 2021. Milione had spent four years at Guidepost prior to his return, leveraging his extensive experience and contacts from a 21-year DEA career. Milione is the most senior of a slew of DEA officials to have traded their badge and gun for a globe-trotting consulting job. His career stands out for two cycles through the revolving door between government and industry, raising questions about the potential impact on the DEA’s mission to police drug companies blamed for tens of thousands of American overdose deaths. Milione’s private-sector clientele also included Morris & Dickson Co., the nation’s fourth-largest wholesale drug distributor, as it tried to stave off DEA sanctions for disregarding thousands of suspicious, high-volume orders. The DEA allowed the company to continue shipping drugs for nearly four years after a judge recommended its license be revoked for “cavalier disregard” of rules aimed at preventing opioid abuse. It was not until AP began asking questions this spring that the DEA moved to finally strip the Shreveport, Louisiana-based company of its license to distribute highly addictive painkillers.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.


The world’s biggest PR firm claims to be an expert on trust – but is it?
2023-01-15, The Guardian (One of the UK's Leading Newspapers)
https://www.theguardian.com/business/2023/jan/15/edelman-pr-firm-davos-trust

At the World Economic Forum in Davos, Switzerland this week, the public relations juggernaut Edelman will publish the latest edition of its “trust barometer”, an annual survey that purports to measure whether people around the world trust businesses, governments, NGOs and the media. There’s just one problem: even as Edelman promotes its brand and pursues clients with stern warnings about the importance of trust, critics charge the company appears reluctant to follow its own advice. The firm’s clients have ranged from ExxonMobil to the Saudi government and members of the Sackler family, the former owners of the opioid manufacturer Purdue Pharma. Successful PR firms do more than simply promote and spin – they actually infuse the public discourse with their clients’ perspectives. “These companies are trying not just to manage trust, but to make trust,” [media studies professor Melissa] Aronczyk said. “And if they themselves are the owners of that survey, or barometer, or whatever it is, then, of course, they become the proprietors of that kind of value.” Edelman’s most effective case study might be the firm itself. It has managed to cultivate a reputation for trust even as its business model appears regularly to contradict its advice and its CEO’s admonitions. Over the past four years Edelman has signed about $9.6m worth of deals with the government of Saudi Arabia and companies controlled by the regime, while simultaneously urging businesses to stand up for human rights.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.


US health agency accused of bowing to drug industry with new opioid guidance
2022-12-17, The Guardian (One of the UK's Leading Newspapers)
https://www.theguardian.com/us-news/2022/dec/17/cdc-accused-opioid-guidelines...

The Centers for Disease Control and Prevention (CDC) has been accused of bowing to drug industry pressure after releasing new guidelines that doctors say put lives at risk by rowing back on warnings about the dangers of opioid prescribing. The latest CDC guidelines have caused controversy after dropping specific limits on dosages and lengths of prescribing from a key summary of recommendations used by physicians. Dr Andrew Kolodny, president of Physicians for Responsible Opioid Prescribing, sees the drug industry’s hand behind the change. Kolodny has testified against opioid makers in legal actions over their part in driving the opioid epidemic by pushing sales with false claims about their safety and effectiveness. They include Purdue Pharma, manufacturer of OxyContin, a powerful narcotic pill that kickstarted the US’s opioid epidemic alongside the company’s marketing strategy to see the drugs widely prescribed. Kolody said ... that the drug industry calculated how much the 2016 CDC guidelines would cost it if doctors followed the recommendations to limit prescribing of high dosage pills. “The highest dosage products have had the highest profit margin. It only costs a few extra pennies to make the higher dosage pill, but retail it’s almost double what they get per pill or prescription. So the industry fought very hard to block the release of the 2016 guideline and when that failed they did everything they could to make the guidelines appear controversial. And that worked,” he said.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma from reliable major media sources.


An onslaught of pills, hundreds of thousands of deaths: Who is accountable?
2019-07-20, Washington Post
https://www.washingtonpost.com/investigations/an-onslaught-of-pills-hundreds-...

The origin, evolution and astonishing scale of Americas catastrophic opioid epidemic just got a lot clearer. The drug industry - the pill manufacturers, wholesalers and retailers - found it profitable to flood some of the most vulnerable communities in America with billions of painkillers. They continued to move their product, and the medical community and government agencies failed to take effective action, even when it became apparent that these pills were fueling addiction and overdoses and were getting diverted to the streets. This has been broadly known for years, but this past week, the more precise details became public for the first time. The revelatory data comes from the Drug Enforcement Administration and its Automation of Reports and Consolidated Orders System (ARCOS). This really shows a relationship between the manufacturers and the distributors: They were all in it together, said Jim Geldhof, a retired DEA employee. Were seeing a lot of internal stuff that basically confirms ... that it was all about greed, and all about money. The data shows a trend in pill distribution that, according to the lawsuit plaintiffs, cant be passed off as reasonable therapeutic medical treatment. The industry shipped 76 billion oxycodone and hydrocodone pills across the country from 2006 through 2012, the period covered by the ARCOS data released this past week. These pills didnt flow in a steady stream but were more like a flash flood, spiking from 8.4 billion in 2006 to 12.6 billion in 2012.

Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.


Purdue Pharma accused of 'corrupting' WHO to boost global opioid sales
2019-05-22, The Guardian (One of the UK's leading newspapers)
https://www.theguardian.com/us-news/2019/may/22/purdue-pharma-opioid-world-he...

Purdue Pharma, the drug manufacturer that kickstarted the US opioid epidemic, corruptly influenced the World Health Organization in order to boost painkiller sales across the globe, according to a report by members of Congress. An investigation by Katherine Clark and Hal Rogers, who represent districts in Massachusetts and Kentucky hard hit by the US opioid epidemic, accuses Purdue of replicating its false marketing claims about the safety and effectiveness of opioids to change WHO prescribing guidelines in an attempt to expand foreign markets for its drugs. The web of influence we uncovered paints a picture of a public health organization that has been corrupted by the opioid industry, said Clark. The WHO appears to be lending the opioid industry its voice and credibility, and as a result, a trusted public health organization is trafficking dangerous misinformation that could lead to a global opioid epidemic. The report ... accuses Purdue of using pharma-funded organizations and specialists to influence the writing of WHO policy to encourage much wider prescribing of addictive high-strength opioids across the globe. It said that, as a result, WHO guidelines are serving as marketing materials for Purdue. [The] report alleges two WHO guidelines ... contain dangerously misleading and, in some instances, outright false claims about the safety and efficacy of prescription opioids. Alarmingly, these guidelines mirror Purdues marketing strategies to increase prescriptions and expand sales, the report found.

Note: Many doctors also profited from excessive prescribing of dangerous opioids. And according to a former DEA agent, Congress helped drug companies fuel the opioid epidemic. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.


Giant Companies Took Secret Payments to Allow Free Flow of Opioids
2024-12-17, New York Times
https://www.nytimes.com/2024/12/17/business/pharmacy-benefit-managers-opioids...

In 2017, the drug industry middleman Express Scripts announced that it was taking decisive steps to curb abuse of the prescription painkillers that had fueled America’s overdose crisis. Why hadn’t the middlemen, known as pharmacy benefit managers, acted sooner to address a crisis that had been building for decades? One reason, a New York Times investigation found: Drugmakers had been paying them not to. For years, the benefit managers, or P.B.M.s, took payments from opioid manufacturers, including Purdue Pharma, in return for not restricting the flow of pills. As tens of thousands of Americans overdosed and died from prescription painkillers, the middlemen collected billions of dollars in payments. The P.B.M.s exert extraordinary control over what drugs people can receive and at what price. The three dominant companies — Express Scripts, CVS Caremark and Optum Rx — oversee prescriptions for more than 200 million. The P.B.M.s are hired by insurers and employers to control their drug costs by negotiating discounts with pharmaceutical manufacturers. They often pursue their own financial interests in ways that increase costs for patients, employers and government programs, while driving independent pharmacies out of business. Regulators have accused the largest P.B.M.s of anticompetitive practices. In addition ... P.B.M.s sometimes collaborated with opioid manufacturers to persuade insurers not to restrict access to their drugs.

Note: A former DEA agent has said that Congress helped drug companies create the opioid epidemic. Read how pharmacy benefit managers inflate the price of medications behind the scenes. For more along these lines, read our concise summaries of news articles on Big Pharma corruption.


As Drug Crisis Mounted, Sacklers Gave Millions to Group That Advises on Opioids
2023-04-23, New York Times
https://www.nytimes.com/2023/04/23/health/sacklers-opioids-national-academies...

For the past decade, the White House and Congress have relied on the National Academies of Sciences, Engineering and Medicine, a renowned advisory group, to help shape the federal response to the opioid crisis, whether by convening expert panels or delivering policy recommendations and reports. Yet officials with the National Academies have kept quiet about one thing: their decision to accept roughly $19 million in donations from members of the Sackler family, the owners of Purdue Pharma, the maker of the drug OxyContin that is notorious for fueling the opioid epidemic. The opioid crisis has led to hundreds of thousands of overdose deaths, spawned lawsuits and forced other institutions to publicly distance themselves from Sackler money or to acknowledge potential conflicts of interest from ties to Purdue Pharma. The National Academies has largely avoided such scrutiny as it continues to advise the government on painkillers. Institutions that more publicly examined their use of Sackler donations include Tufts University, which released a review of possible conflicts of interest related to pain research education funded by Purdue Pharma. Concerns noted in the report included a senior Purdue executive’s delivering lectures to students each semester. The World Health Organization in 2019 retracted two guidance documents on opioid policy after lawmakers aired concerns about ties to opioid makers, including a Purdue subsidiary, among report authors and funders.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.


Federal Prisons Were Told to Provide Addiction Medications. Instead, They Punish People Who Use Them
2022-12-12, The Marshall Project
https://www.themarshallproject.org/2022/12/12/suboxone-federal-prison-opioid-...

Timothy York knows what works to treat his decades-long opioid addiction: Suboxone, a medication that effectively quiets cravings. In 2019, he was relieved to learn that the federal Bureau of Prisons was starting a program to expand access to Suboxone. He’s still waiting. In the meantime, he’s been punished for using Suboxone without a prescription. Last year, after York, 46, was caught with the medication, he spent a month in solitary confinement and had his visitor privileges revoked for a year. York is not alone. The Marshall Project spoke to more than 20 people struggling with addictions in federal prison, and they described the dire consequences of being unable to safely access a treatment that Congress has instructed prisons to provide. Some have overdosed. The lack of Suboxone treatment comes amid a rise in drug-related deaths behind bars. A variety of substances are routinely smuggled into prisons and jails through mail, drone drops, visitors or corrections officers and other staff. In the last two decades, federal data shows that fatal overdoses increased by more than 600% inside prisons and more than 200% inside jails. Forty-seven incarcerated people died of overdoses in federal prison from 2019 through 2021. The data does not specify how many of these overdose deaths were caused by opioids and could have been prevented by medications like Suboxone. During the same period, correctional staff administered Narcan — a drug that reverses opioid overdoses — almost 600 times.

Note: For more along these lines, see concise summaries of deeply revealing news articles on prison system corruption from reliable major media sources.


“American Cartel” A Conversation with Alex Gibney, Sari Horwitz and Scott Higham
2022-07-12, Washington Post
https://www.washingtonpost.com/washington-post-live/2022/07/12/transcript-ame...

Today it’s my great pleasure to introduce two Pulitzer Prize-winning Washington Post journalists, Sari Horwitz and Scott Higham, who are going to discuss their new book, "American Cartel." We're talking about companies that create and fuel the opioid crisis. We've heard this story about the Sacklers and indeed the Sacklers have been identified, and if criminal charges haven't been brought at least they've been vilified in the press. But ... this goes way beyond the Sacklers. This is not just the story of one bad apple. "It's so much bigger than that," [said Horwitz]. "We found, in our two-year investigation ... a constellation of companies that fuel the deadliest epidemic, drug epidemic, in American history. Some of these companies are some of the largest in this country. Some we've heard of. They are household names - Walgreens, Walmart, Johnson & Johnson. We found internal emails from these companies where the people in the companies were laughing at the addicts. They were mocking them. Meanwhile, the drug companies, they are smart. They decide to lure away the best and the brightest if they can from the DEA and the Justice Department to help them as they are selling opioids, and they are very successful. They hired dozens of people from DEA and the Justice Department to work for these companies. So again, these are the people who are trying to protect us, working for the DEA and the Justice Department. They are lured away to the companies who are selling addictive painkillers that are killing people."

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering from reliable major media sources.


Lawyers seek to halt Purdue Pharma political contributions
2020-07-11, Associated Press
https://apnews.com/0f5546a3fb25e50f029bdd1ec8a4424a

OxyContin maker Purdue Pharma should not be able to make any more political contributions without a judges permission, lawyers for its creditors said in a court filing. The issue came up this week after it was reported that the company, which has a long history of influencing policymakers, made contributions to national associations representing state attorneys general and governors. The money was sent after Purdue entered bankruptcy protection last year in an effort to settle thousands of lawsuits accusing it of helping spark an opioid addiction and overdose epidemic that has contributed to more than 400,000 deaths in the U.S.. State attorneys general are among those trying to negotiate a nationwide settlement. The committee of creditors that asked for recipients to return the money to Purdue said the contributions represent a conflict. The Political Contributions $185,000 in donations to associations whose members include the very public servants with whom the Debtors are attempting to negotiate a consensual resolution of these cases are precisely the sort of transaction that demand close scrutiny, they said in a filing. In 2016, an investigation by The Associated Press and the Center for Public Integrity found that Purdue and other companies in the opioid industry, along with the advocacy groups largely funded by the industry, spent more than $880 million from 2006 through 2015 to influence state and local governments. Those efforts helped fight off restrictions on drug prescriptions.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.


Rudy Giuliani won deal for OxyContin maker to continue sales of drug behind opioid deaths
2018-05-22, The Guardian (One of the UK's leading newspapers)
https://www.theguardian.com/us-news/2018/may/22/rudy-giuliani-opioid-epidemic...

The US government missed the opportunity to curb sales of the drug that kickstarted the opioid epidemic when it secured the only criminal conviction against the maker of OxyContin a decade ago. Purdue Pharma hired Rudolph Giuliani, the former New York mayor and now Donald Trumps lawyer, to head off a federal investigation in the mid-2000s into the companys marketing of the powerful prescription painkiller at the centre of an epidemic estimated to have claimed at least 300,000 lives. While Giuliani was not able to prevent the criminal conviction over Purdues fraudulent claims for OxyContins safety and effectiveness, he was able to reach a deal to avoid a bar on Purdue doing business with the federal government which would have killed a large part of the multibillion-dollar market for the drug. The former New York mayor also secured an agreement that greatly restricted further prosecution of the pharmaceutical company and kept its senior executives out of prison. The US attorney who led the investigation, John Brownlee, has ... expressed surprise that Purdue did not face stronger action. Purdue is now facing ... civil lawsuits [in] New York, Texas and five other states. But Brownlee was the first, and so far only, prosecutor to secure a criminal conviction against the drug maker. Brownlees office discovered training videos in which reps acted out selling the drug using the false claims. This was ... pushed from the highest levels of the company, said Brownlee.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma.


Drug company founder John Kapoor arrested for alleged opioid scheme
2017-10-26, CBS News
https://www.cbsnews.com/news/drug-company-founder-john-kapoor-arrested-for-al...

Federal agents arrested the founder of a major drug company in an early-morning raid Thursday on charges stemming from an alleged scheme to get doctors to illegally prescribe a powerful opioid to patients who don't need it. John Kapoor ... is the billionaire founder and former CEO of the pharmaceutical company Insys Therapeutics. He faces charges including racketeering, conspiracy, bribery and fraud. Kapoor is the most significant pharmaceutical executive to be criminally charged in response to the nationwide opioid crisis. Kapoor stepped down as CEO of Insys in January but still serves on its board. The company makes a spray version of fentanyl, a highly addictive opioid intended only for cancer patients. Authorities allege Insys marketed the drug as part of a scheme to get non-cancer doctors to prescribe it. Numerous physicians were allegedly paid bribes by the company to push the painkilling drug. Insys made 18,000 payments to doctors in 2016 that totaled more than $2 million. Headache doctors, back pain specialists and even a psychiatrist ... received thousands of dollars to promote the drug last year. Last December, six other Insys executives were indicted on federal charges in Boston in connection with the alleged scheme to bribe doctors to unnecessarily prescribe the painkilling drug.

Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption and health.


Ex-DEA agent: Opioid crisis fueled by drug industry and Congress
2017-10-15, CBS News
https://www.cbsnews.com/news/ex-dea-agent-opioid-crisis-fueled-by-drug-indust...

In the midst of the worst drug epidemic in American history, the U.S. Drug Enforcement Administration's ability to keep addictive opioids off U.S. streets was derailed - that according to Joe Rannazzisi, one of the most important whistleblowers ever interviewed by 60 Minutes. Rannazzisi ran the DEA's Office of Diversion Control, the division that regulates and investigates the pharmaceutical industry. He says the opioid crisis was allowed to spread - aided by Congress, lobbyists, and a drug distribution industry that shipped, almost unchecked, hundreds of millions of pills to rogue pharmacies and pain clinics providing the rocket fuel for a crisis that, over the last two decades, has claimed 200,000 lives. His greatest ire is reserved for the ... middlemen that ship the pain pills from manufacturers, like Purdue Pharma and Johnson & Johnson to drug stores all over the country. Rannazzisi accuses the distributors of fueling the opioid epidemic. "This is an industry that allowed millions and millions of drugs to go into bad pharmacies and doctors' offices, that distributed them out to people who had no legitimate need for those drugs," [said Rannazzisi]. In 2013, Joe Rannazzisi and his DEA investigators were trying to crack down. Then ... with the help of members of Congress, the drug industry began to quietly pave the way for legislation that essentially would strip the DEA of its ... ability to immediately freeze suspicious shipments of prescription narcotics to keep drugs off U.S. streets.

Note: See also this informative Washington Post article for more information on this sad topic. Lots more available here. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in pharmaceutical industry.


The Drug Industry's Triumph Over the DEA
2017-10-15, Washington Post
https://www.washingtonpost.com/graphics/2017/investigations/dea-drug-industry...

In April 2016, at the height of the deadliest drug epidemic in U.S. history, Congress effectively stripped the Drug Enforcement Administration of its most potent weapon against large drug companies suspected of spilling prescription narcotics onto the nations streets. By then, the opioid war had claimed 200,000 lives. Overdose deaths continue to rise. A handful of members of Congress, allied with the nations major drug distributors, prevailed upon the DEA and the Justice Department to agree to a more industry-friendly law. The new law makes it virtually impossible for the DEA to freeze suspicious narcotic shipments from the companies, according to internal agency and Justice Department documents and an independent assessment. Political action committees representing the industry contributed at least $1.5 million to the 23 lawmakers who sponsored or co-sponsored four versions of the bill. The drug industry, the manufacturers, wholesalers, distributors and chain drugstores, have an influence over Congress that has never been seen before, said Joseph T. Rannazzisi, who ran the DEAs division responsible for regulating the drug industry and led a decade-long campaign of aggressive enforcement until he was forced out of the agency in 2015. I mean, to get Congress to pass a bill to protect their interests in the height of an opioid epidemic just shows me how much influence they have. The DEA and Justice Department have denied or delayed more than a dozen requests filed by The Post and 60 Minutes under the Freedom of Information Act for public records that might shed additional light on the matter.

Note: The city of Everett, Washington is currently suing Purdue Pharma, maker of the opioid pain medication OxyContin, for the company's alleged role in the diversion of its pills to black market buyers. For other reliable information on pharmaceutical involvement in the huge increase in opioid deaths, see Dr. Mercola's excellent article. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in pharmaceutical industry.


Many Doctors Get Goodies from Opioid Makers
2017-08-10, NBC News
https://www.nbcnews.com/storyline/americas-heroin-epidemic/many-doctors-get-g...

About one out of every 12 U.S. doctors gets money, lunch or something else of value from companies that make opioid drugs, researchers reported Wednesday. Companies are spending much more time and effort marketing opioids to doctors than they are other, less addictive painkillers, the researchers found. They say their findings help explain why doctors have played such an important role in the opioid overuse epidemic. A large proportion of physicians received payments - one in 12 physicians overall, said Dr. Scott Hadland of the Boston Medical Center. Tens of millions of dollars were transferred for marketing purposes for opioids. In some cases they are money provided directly to physicians - for example, the speaking fees, the consultant fees and the honoraria. In other cases it is reimbursement for things like travel, Hadland said. Between 2013 and 2015, the team found 375,266 payments worth $46 million made to more than 68,000 doctors. The top 1 percent of physicians (681 of them) received 82.5 percent of total payments in dollars, the team wrote in their report. A study published last year found that physicians who accepted even one meal sponsored by a drug company were much more likely to prescribe a name-brand drug to patients later. The Centers for Disease Control and Prevention says doctors are definitely helping drive the addiction crisis. The result is deadly. More than 30,000 Americans died from opioid overdoses in 2015.

Note: The city of Everett, Washington is currently suing Purdue Pharma, maker of the opioid pain medication OxyContin, for the company's alleged role in the diversion of its pills to black market buyers. For other reliable information on pharmaceutical involvement in the huge increase in opioid deaths, see Dr. Mercola's excellent article. For more along these lines, see concise summaries of deeply revealing pharmaceutical corruption news articles from reliable major media sources.